our board of directors
The collective experience that our Board of Directors brings to TRIA Beauty provides us with unparalleled expertise from a wide range of
industries including laser technology, financial services, health care, beauty and personal care.
In addition to Messrs. Appelbaum and Grove, our Directors include:
Albert Cha, M.D., Ph.D.
Managing Partner, Vivo Ventures
http://www.vivoventures.com
- Serves or has served on the boards of Biodel (NASDAQ: BIOD) and Bioform Medical (NASDAQ: BFRM) as well as several private biotechnology
and medical device companies
- Prior professional experience at Oracle Corporation in pharmaceutical consulting; Palo Alto VA Hospital as a biomedical engineer;
and as founding or interim CEO for several Vivo portfolio companies
- B.S. and M.S. in Electrical Engineering, Stanford; M.D. and Ph.D. in Neuroscience, UCLA Medical School
Steve Elms
Managing Director, Aisling Capital
http://www.aislingcapital.com
- Serves as a director of Advion BioSciences, Inc., Ambit Biosciences Corporation, Avera Pharmaceuticals, Inc., Bioenvision, Inc.,
CeNeRx BioPharma, Inc. and MAP Pharmaceuticals, Inc., Archimica Co?peratief U.A., and NextWave Pharmaceuticals, Inc.
- Former Principal in the Life Sciences Investment Banking Group of H&Q
- Prior experience as a trader of mortgage-backed securities at Donaldson, Lufkin & Jenrette for two years
- B.A. in Human Biology, Stanford; M.B.A. from the Kellogg School of Management at Northwestern University.
James Glasheen, Ph.D.
General Partner, Technology Partners
http://www.technologypartners.com
- Former Managing Director at CIT Venture Capital, leading the Group's efforts in Life Science investing
- Former leader within McKinsey & Company's Pharmaceutical and Medical Products Practice
- Advisor to National Science Foundation (NSF) Small Business Innovation Research (SBIR) program
- B.S. In Biology/Mechanical Engineering, Duke; M.A. and Ph.D. in Biology, Harvard University
David M. Mauney, MD
Managing Director, De Novo Ventures
http://www.denovovc.com
- Co-founder of De Novo Ventures
- Serves on the boards of Articulinx, Applied Spine, ProMed, Simpirica, TRIA Beauty, VeinRx and Ventus Medical
- Former partner at Asset Management Company, where he worked with Pitch Johnson as the lead partner in healthcare investments.
- Former director of Business Development for Fox Hollow Technologies
- BA, Duke; M.D., Dartmouth School of Medicine
Jeffrey M. Nugent, Chairman of the Board
President and CEO, Ventus Medical
http://www.ventusmedical.com
- Former President and Chief Executive Officer, Revlon, Inc.
- Former President and Chief Executive Officer, Neutrogena Corp.
- Vice President of Worldwide Quality Management, Director of Marketing for Health Care Consumer Products, and Director of
Research & Development for Johnson & Johnson
